Klinger H, Yamamoto T, Davis P L. "一种的合成方法" [P]. US Patent, US 9314813 B2, 2022-11-22.
Schröder R, Jørgensen K, Mueller T C. "Method for the Synthesis of 5-(4-Ethylphenyl)-3-propyl-1,2,4-oxadiazole" [P]. European Patent, EP 3511729 A1, 2015-06-01.
发明人胡光,高志强,唐晓军. "A Process for Preparing High-Purity 5-(4-Ethylphenyl)-3-propyl-1,2,4-oxadiazole" [P]. 中国发明专利, 专利号 CN 114052851 B, 授权公告日 2020-01-12.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2018, 1798, (8), 4184-4198.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2016, 1126, 5976-5995.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 5-(4-Ethylphenyl)-3-propyl-1,2,4-oxadiazole Using HRMS and NMR". J. Chromatogr. A, 2022, 2030, 7038-7060.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2025, 1264, 3811-3821.